EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC 4.0

Biomarkers for monitoring alcohol sobriety after liver transplantation for alcoholic liver disease

Jiang Liu, Kwan Man iD

Journal of Gastroenterology and Hepatology · 2023

DOI: 10.1111/jgh.16269 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Gastroenterology and Hepatology, 2023. Verfasst von Jiang Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, LKS Faculty of Medicine and HKU-Shenzhen Hospital, The University of Hong Kong, Hong Kong, Hong Kong. Hauptthemen laut MEDLINE: Liver Transplantation, Liver Diseases, Alcoholic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Research Grants Council, University Grants Committee.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alcoholic liver disease (ALD) has become the most common indication for liver transplantation in Western countries, and its incidence is rapidly increasing in East Asia. Alcohol abstinence remains the standard of care for promoting liver transplantation for ALD and for preventing posttransplant graft loss. However, efficient monitoring methods are still being developed due to the limitations of traditional biomarkers, interviews, and questionnaires. The development of alcohol biomarkers has shifted from detecting alcohol and methanol to indirect byproducts, and to current mid‐term and long‐term direct alcohol metabolites, which provide higher accuracy and cover almost all types of alcohol relapse detection. However, in most clinical studies, biomarkers are used and validated in healthy individuals and alcohol use disorder (AUD) patients and for pretransplant evaluations. The evidence for their use in posttransplant abstinence monitoring is still lacking, but it is crucial for early detection of alcohol relapse and initiating intervention. This review aims to summarize the current evidence of the use of biomarkers for monitoring sobriety and alcohol relapse after liver transplantation, as well as to cover the diagnostic accuracy, detection window, and optimal multidisciplinary strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Liver TransplantationLiver Diseases, AlcoholicHumansAlcohol DrinkingEthanolBiomarkersRecurrence

Stichwörter der Autor:innen

Alcoholic liver diseaseBiomarkerLiver transplantationSobriety

Substanzen

EthanolBiomarkers

Autor:innen und Institutionen

  • Department of Surgery, LKS Faculty of Medicine and HKU-Shenzhen Hospital, The University of Hong Kong, Hong Kong, Hong Kong.
  • Hepato-pancreato-biliary Center, Beijing Tsinghua Changgung Hospital, Tsinghua University, Beijing, China.

ORCID-Profile: Kwan Man

Förderung

  • Research Grants Council, University Grants Committee

Zitieren

APA

Liu, J., & Man, K. (2023). Biomarkers for monitoring alcohol sobriety after liver transplantation for alcoholic liver disease. Journal of Gastroenterology and Hepatology. https://doi.org/10.1111/jgh.16269

Vancouver

Liu J, Man K. Biomarkers for monitoring alcohol sobriety after liver transplantation for alcoholic liver disease. Journal of Gastroenterology and Hepatology. 2023. doi:10.1111/jgh.16269

BibTeX
@article{Liu2023,
  author = {Liu, Jiang and Man, Kwan},
  title = {Biomarkers for monitoring alcohol sobriety after liver transplantation for alcoholic liver disease},
  journal = {Journal of Gastroenterology and Hepatology},
  year = {2023},
  doi = {10.1111/jgh.16269}
}
Kostenlos starten →